IGENEX INC NPI 1396837605

NPI Details

IGENEX INC is a clinical medical laboratory in Milpitas, CA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. IGENEX INC NPI is 1396837605. The provider is registered as an organization entity type.
The provider Is Doing Business As Igenex, Inc. Reference Laboratory.

The provider's business location address is:

556 GIBRALTAR DR
MILPITAS, CA
ZIP 95035-315
Phone: (800) 832-3200
Fax: (650) 424-1196

The provider's authorized official is Jyotsna S Shah .
The authorized official title is Ceo/ Lab Director and has the following contact phone number (800) 832-3200.

The CLIA number assigned to this NPI record is 05D0643914 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Analysis for antibody bacteria (HCPCS:86609)
• Detection of infectious agent antibody, quantitative (HCPCS:86317)
• Analysis for antibody to bartonella (bacteria) (HCPCS:86611)
• Analysis for antibody to ehrlichia (bacteria transmitted by ticks) (HCPCS:86666)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Analysis for antibody to protozoa (parasite) (HCPCS:86753)
• Analysis for antibody to rickettsia (bacteria) (HCPCS:86757)
• Genetic sequencing localization, initial procedure (HCPCS:88365)
• Confirmation test for antibody to borrelia burgdorferi (lyme disease bacteria) (HCPCS:86617)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Analysis for antibody to borrelia (relapsing fever bacteria) (HCPCS:86619)
• Detection test by immunofluorescent technique for organism (HCPCS:87299)
• Igm antibody detection test for borrelia burgdorferi (HCPCS:0041U)
• Igg antibody detection test for borrelia burgdorferi (HCPCS:0042U)
• Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
• Detection by nucleic acid for borrelia burgdorferi (bacteria), amplified probe technique (HCPCS:87476)
• Igm antibody detection test for tick-borne relapsing fever borrelia group (igm) (HCPCS:0043U)
• Igm antibody detection test for tick-borne relapsing fever borrelia group (igg) (HCPCS:0044U)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Protein measurement, immunological probe for band identification (HCPCS:84182)
• Detection test by immunoassay technique for multiple organisms, each polyvalent antiserum (HCPCS:87451)
• Test for detection of infectious agent antibody, qualitative or semiquantitative (HCPCS:86318)
• Detection by nucleic acid bartonella henselae and bartonella quintana (bacteria), amplified probe technique (HCPCS:87471)
• Analysis of cell function and analysis for genetic marker (HCPCS:86352)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Analysis for antibody to chlamydia (bacteria) (HCPCS:86631)
• Detection test by immunoassay technique for other organism (HCPCS:87449)
• Detection test by nucleic acid for organism, direct probe technique (HCPCS:87797)

The enumeration date for this NPI number is 9/28/2006 and was last updated on 2/19/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: